TNFRSF11B and chronic kidney disease: Circulating OPG levels increase with initiation of atherogenic diet, while exogenous OPG injection inhibits vascular calcification [12,13,14], indicating circulating OPG as a biomarker, but not a mediator, of atherosclerosis that is also closely related to CKD.